Niki BioSolutions, Inc. (APM) Form 8-K — Jul 20, 2026
Aptorum Group Limited completed its previously announced merger with DiamiR Biosciences Corp., resulting in the domestication of the company to Delaware and a name change to Niki BioSolutions, Inc. DiamiR became a wholly-owned subsidiary of Aptorum, with 1,979,216 shares of Niki Common Stock issued to former DiamiR stockholders based on the agreed conversion ratio. Concurrent with the merger closing, the company effected a 10-for-1 reverse stock split of its Class A and Class B ordinary shares to maintain compliance with Nasdaq's minimum bid price requirement.
Key figures
- New cusip
- 653942102
- New ticker
- NIKI
- Reverse split ratio
- 1:10
- Diamir shares converted
- 1979216
- Pre split class a shares
- 6346823
- Pre split class b shares
- 1796934
- Post split class a shares
- 634682
- Post split class b shares
- 179693
- Series a preferred issued
- 179693
- Authorized class a post split
- 999999600
- Authorized class b post split
- 400000
- Series a preferred authorized
- 1810000
Price after filing
Close on the filing date to close N calendar days later (from $8.83). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.